Printer Friendly

BIO-VASCULAR ANNOUNCES NEW VICE PRESIDENT OF OPERATIONS

 BIO-VASCULAR ANNOUNCES NEW VICE PRESIDENT OF OPERATIONS
 ST. PAUL, Minn., Nov. 11 /PRNewswire/ -- Bio-Vascular, Inc.


(NASDAQ: BVAS), a St. Paul, Minn., company, announced that Robert Nelson has joined the management team as vice president of operations.
 Nelson was formerly the director of U.S. operations for Rexton, Inc. of Plymouth, Minn. Rexton, Inc., a Swiss-based division of Siemens AG of Munich, Germany, is involved in the distribution and manufacturing of custom hearing aids. Prior to his employment with Rexton, Inc., Nelson was the director of quality, manufacturing and engineering for Medtronic, Inc.'s Heart Valve Division.
 John H. Darnall, Jr., chief executive officer of Bio-Vascular, Inc., stated, "Mr. Nelson's experience and skills will be important to our growth and development. We are very pleased that he has joined the Bio-Vascular team."
 Bio-Vascular, Inc., is a manufacturer and distributor of proprietary consumable medical products used in cardiac and vascular surgery. Bio-Vascular's stock is traded on the national-over-the-counter market under the symbol BVAS (common stock).
 -0- 11/11/91
 /CONTACT: John Darnall, Jr., president and CEO of Bio-Vascular, Inc., 612-631-3529/
 (BVAS) CO: Bio-Vascular, Inc. ST: Minnesota IN: MTC SU: PER AL -- MN016 -- 3067 11/11/91 13:10 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 11, 1991
Words:197
Previous Article:DISCUS ANNOUNCES THIRD QUARTER RESULTS
Next Article:PYRAMID TEAMS WITH CGS TO FORM WORLDWIDE OPEN SYSTEMS INTEGRATION PARTNERSHIP
Topics:


Related Articles
BIO-VASCULAR ANNOUNCES NEW DIRECTOR OF REGULATORY AFFAIRS
MEDTRONIC REASSIGNS TWO EXECUTIVES IN NEUROLOGICAL, INTERVENTIONAL VASCULAR BUSINESSES
BIO-VASCULAR NAMES SCHANKERELI DIRECTOR OF RESEARCH AND DEVELOPMENT
DARNALL RESIGNS AS BIO-VASCULAR CHIEF EXECUTIVE; THREE EXECUTIVES TO FORM NEW OFFICE OF PRESIDENT
BIO-VASCULAR PICKS LYONS AS CHIEF EXECUTIVE OFFICER
BIO-VASCULAR NAMES KEMAL SHANKERELI VICE PRESIDENT OF RESEARCH AND DEVELOPMENT
BIO-VASCULAR NAMES KARCANES AS PRESIDENT AND CHIEF OPERATING OFFICER
KARCANES ELECTED CEO OF BIO-VASCULAR, INC.
BIO-VASCULAR PROMOTES BRUCE A. MACFARLANE, PH.D., TO VICE PRESIDENT, REGULATORY AFFAIRS AND QUALITY ASSURANCE
JOSEPH TARTAGLIA JOINS MEDTRONIC INTERVENTIONAL VASCULAR AS VICE PRESIDENT, PRODUCT DEVELOPMENT/OPERATIONS IN SAN DIEGO

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters